Tirzepatide Dosage Chart
Every tirzepatide dose in the FDA labels for Zepbound and Mounjaro, from the 2.5 mg starting dose to the 15 mg maximum, with the mL and units to draw from a brand vial. Brand doses are always 0.5 mL (50 units) from a single-dose vial and 0.6 mL (60 units) from a multi-dose vial. Compounded vials depend on their concentration, shown further down.
Tirzepatide dosage chart by week
The Zepbound and Mounjaro labels start at 2.5 mg once weekly for 4 weeks. 2.5 mg is only for starting treatment, not a maintenance dose. After that the dose goes up in 2.5 mg steps, with at least 4 weeks on each dose. Zepbound lists 5 mg, 10 mg or 15 mg as maintenance doses for weight reduction and 10 mg or 15 mg for obstructive sleep apnea. The maximum is 15 mg once weekly. The weeks in the table are the earliest a dose can start under the label; the prescriber decides the actual schedule.
Brand vial strengths for each dose
Compounded vials: dose in mL and units
For a compounded vial, divide the dose by the mg/mL on the pharmacy label for mL, then multiply by 100 for units. The table works this out at five example concentrations; if yours is different, use the calculator below.
* More than 100 units: does not fit in a 1 mL syringe in one draw.
Convert your own dose
Follow your prescription and pharmacy label. Ask the prescriber or pharmacist if anything is unclear.
Concentration: 5 mg ÷ 0.5 mL = 10 mg/mL. The label dose is 0.5 mL, the whole vial.
5 mg = 50 units(0.5 mL at 10 mg/mL)
- Step 1. Concentrationmg/mL = mg in vial ÷ mL in vial5 mg ÷ 0.5 mL = 10 mg/mL
- Step 2. VolumemL = mg ÷ (mg/mL)5 ÷ (5 ÷ 0.5) = 0.5 mL
- Step 3. Units on a U-100 syringeunits = mL × 1000.5 × 100 = 50 units
Units vs mg
A mg (milligram) is the amount of tirzepatide. A unit is a mark on a U-100 insulin syringe, and on a U-100 syringe 100 units fill 1 mL, so 1 unit is 0.01 mL. Units measure volume, not drug. How much tirzepatide is in those units depends on how concentrated the liquid is.
Why the vial concentration matters
The same dose can be very different volumes. 2.5 mg is 25 units only at 10 mg/mL. At 5 mg/mL it is 50 units, and at 25 mg/mL it is 10 units. That is why this calculator asks for the vial first and never assumes a concentration.
Brand vs compounded vials
Brand tirzepatide vials (Zepbound and Mounjaro) are made so every dose is the same volume: 0.5 mL (50 units) from a single-dose vial, or 0.6 mL (60 units) from a multi-dose vial that holds 4 doses. The vial strength changes with the dose instead. Compounded vials are prepared by a pharmacy at a concentration of its choosing, so the volume for a given dose changes from vial to vial. Read the mg/mL on the pharmacy label.
Each dose in units
- How many units is 2.5 mg?
- How many units is 5 mg?
- How many units is 7.5 mg?
- How many units is 10 mg?
- How many units is 12.5 mg?
- How many units is 15 mg?
Or go back to the tirzepatide units to mg calculator.
Frequently asked questions
- What is the tirzepatide dosing for weight loss in units?
- With brand vials every dose is the same volume: 50 units (0.5 mL) from a single-dose vial or 60 units (0.6 mL) from a multi-dose vial, for every dose from 2.5 mg to 15 mg. With a compounded vial, units = mg ÷ (mg/mL) × 100, so it depends on the concentration on the label.
- What is the tirzepatide dosing in mL?
- 0.5 mL per dose from a brand single-dose vial and 0.6 mL per dose from a brand multi-dose vial. For a compounded vial, mL = mg ÷ (mg/mL): for example 5 mg at 10 mg/mL is 0.5 mL.
- How long does each tirzepatide dose step last?
- The labels start at 2.5 mg once weekly for 4 weeks, then increase in 2.5 mg steps after at least 4 weeks on the current dose. The maximum is 15 mg once weekly. The prescriber sets the actual schedule.
- Which tirzepatide doses are maintenance doses?
- The Zepbound label lists 5 mg, 10 mg or 15 mg as maintenance doses for weight reduction, and 10 mg or 15 mg for obstructive sleep apnea. 2.5 mg is only a starting dose.
Sources
- Zepbound (tirzepatide) prescribing information (DailyMed, effective 2026-08-28)
- Mounjaro (tirzepatide) prescribing information (DailyMed, effective 2026-08-27)
Doses and vial strengths checked against these labels on 2026-10-22.